Insufficient scRNA-seq data for expression of ANXA9 at single-cell level.
Insufficient scRNA-seq data for expression of ANXA9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1004.92 | 226 / 226 | 98% | 100.46 | 399 / 406 |
pancreas | 100% | 1124.55 | 328 / 328 | 95% | 44.37 | 169 / 178 |
kidney | 100% | 919.40 | 89 / 89 | 87% | 22.54 | 788 / 901 |
thymus | 100% | 908.94 | 652 / 653 | 87% | 53.15 | 524 / 605 |
breast | 83% | 281.71 | 379 / 459 | 93% | 100.61 | 1038 / 1118 |
intestine | 93% | 189.89 | 900 / 966 | 81% | 18.49 | 429 / 527 |
brain | 74% | 169.35 | 1957 / 2642 | 96% | 22.65 | 674 / 705 |
stomach | 92% | 197.29 | 330 / 359 | 77% | 18.75 | 221 / 286 |
ovary | 98% | 281.59 | 176 / 180 | 70% | 18.28 | 301 / 430 |
bladder | 86% | 318.81 | 18 / 21 | 82% | 50.36 | 411 / 504 |
prostate | 90% | 205.49 | 220 / 245 | 75% | 12.23 | 374 / 502 |
uterus | 100% | 413.57 | 170 / 170 | 64% | 22.40 | 294 / 459 |
esophagus | 92% | 526.78 | 1333 / 1445 | 51% | 15.09 | 93 / 183 |
skin | 73% | 1484.72 | 1327 / 1809 | 66% | 13.52 | 313 / 472 |
lung | 73% | 142.18 | 421 / 578 | 63% | 13.17 | 722 / 1155 |
adrenal gland | 82% | 157.99 | 211 / 258 | 49% | 7.97 | 113 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 83.92 | 1 / 1 |
spleen | 90% | 180.74 | 218 / 241 | 0% | 0 | 0 / 0 |
adipose | 71% | 202.92 | 857 / 1204 | 0% | 0 | 0 / 0 |
heart | 67% | 121.75 | 576 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 49% | 11.26 | 22 / 45 |
peripheral blood | 48% | 176.90 | 446 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 41% | 61.12 | 551 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 34% | 4.07 | 27 / 80 |
muscle | 12% | 16.34 | 96 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.34 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0007271 | Biological process | synaptic transmission, cholinergic |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0045202 | Cellular component | synapse |
GO_0012506 | Cellular component | vesicle membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0015464 | Molecular function | acetylcholine receptor activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0005515 | Molecular function | protein binding |
GO_0005544 | Molecular function | calcium-dependent phospholipid binding |
GO_0005543 | Molecular function | phospholipid binding |
Gene name | ANXA9 |
Protein name | Annexin A9 (Annexin XXXI) (Annexin-31) (Annexin-9) (Pemphaxin) |
Synonyms | ANX31 |
Description | FUNCTION: Low affinity receptor for acetylcholine known to be targeted by disease-causing pemphigus vulgaris antibodies in keratinocytes. . |
Accessions | O76027 ENST00000368947.9 |